Tokyo, Dec. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059995) titled 'Systematic Review and Meta-Analysis on the Effects of Cocoa Flavanol Intake on Blood Pressure and Its Implications for Cardiovascular Disease Risk Reduction' on Dec. 5.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Meiji Co., Ltd.
Condition:
Condition - Healthy adult
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to comprehensively analyze the effects of cocoa flavanol intake on blood pressure and to clarify its association with cardiovascular disease (CVD) risk reduction.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Interventional studies involving healthy adults or individuals with hypertension, including stage 1 to 3 hypertension.
Studies that report blood pressure (systolic and/or diastolic) as a primary or secondary outcome.
Randomized controlled trials (RCTs) with placebo or non-intake control groups.
Key exclusion criteria - Studies involving minors or pregnant and lactating women.
Studies using an intervention product where the specific content of cacao flavanols is not specified.
Studies using an intervention product that contains ingredients, other than cacao flavanols, which could potentially affect blood pressure.
Studies using a control product that contains ingredients which could potentially affect blood pressure.
Studies that include co-interventions, such as dietary modifications or exercise, which could potentially affect blood pressure.
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 12 Month 05 Day
Anticipated trial start date - 2025 Year 12 Month 08 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068615
Disclaimer: Curated by HT Syndication.